Tianying Tong

State Key Laboratory Of Systems Medicine For Cancer, NHC Key Laboratory Of Digestive Diseases
Shanghai, 200001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Optimizing anti-PD-1/PD-L1 therapy efficacy and fecal microbiota transplantation donor selection through gut mycobiome-based enterotype.

Journal: Cell reports
Published: August 01, 2024

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Journal: Cell metabolism
Published: July 02, 2024

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Interplay between gut microbial communities and metabolites modulates pan-cancer immunotherapy responses.

Journal: Cell metabolism
Published: April 14, 2024

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

Journal: Cell host & microbe
Published: September 28, 2023

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts.

Journal: Nature communications
Published: May 24, 2023

Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts.

Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts.

Journal: Cell host & microbe
Published: May 13, 2023

Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.

Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis.

Journal: Gut
Published: April 04, 2023

Gut microbiome for predicting immune checkpoint blockade-associated adverse events.

Gut microbiome for predicting immune checkpoint blockade-associated adverse events.

Journal: Genome medicine
Published: March 08, 2023

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine.

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine.

Journal: Frontiers in immunology
Published: January 15, 2023

Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability.

Commensal bacteria promote azathioprine therapy failure in inflammatory bowel disease via decreasing 6-mercaptopurine bioavailability.

Journal: Cell reports. Medicine
Published: November 28, 2022

Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis.

Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis.

Journal: Cell metabolism
Published: September 14, 2022

LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51.

LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51.

Journal: Oncogene
Published: August 18, 2022
Showing 1-12 of 16

Last Updated: 09/26/2026